Beijing Challen Biotechnology Co., Ltd.
PrivateLast Round
Series C
Apr 27, 2026
Total Funding Raised
$20.6M
Company Overview
Beijing Challen Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C round in April 2026.
Beijing Challen Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sale of flow cytometry instruments and diagnostic reagents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Challen Biotechnology Co., Ltd. Comparables
Compare Beijing Challen Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hubei NewZongke Viral Disease Control Bio-Tech Ltd. | 79% | |
| Cytek Biosciences | 77% | |
| Danaher | 75% |
For institutional investors. Book with your work email.
Beijing Challen Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 27, 2026 | ||||
| Series B | Mar 27, 2024 | ||||
| Series A | Jul 29, 2022 |
For institutional investors. Book with your work email.
Beijing Challen Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series A |
| 荷塘创投 | Series B |
| Addor Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2024
$12.4M round led by 荷塘创投
For institutional investors. Book with your work email.
Beijing Challen Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing Challen Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Challen Biotechnology Co., Ltd. a public or private company?
Beijing Challen Biotechnology Co., Ltd. is a private company.
What is the current stock price of Beijing Challen Biotechnology Co., Ltd.?
Beijing Challen Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Challen Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Challen Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Beijing Challen Biotechnology Co., Ltd. is not publicly available.
Can I buy Beijing Challen Biotechnology Co., Ltd. stock?
Beijing Challen Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Challen Biotechnology Co., Ltd.'s last funding round?
Beijing Challen Biotechnology Co., Ltd.'s most recent funding round was Series C on April 27, 2026.
Who are the main investors in Beijing Challen Biotechnology Co., Ltd.?
Key investors in Beijing Challen Biotechnology Co., Ltd. include IDG Capital, 荷塘创投.
Will Beijing Challen Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Challen Biotechnology Co., Ltd..
How can I track Beijing Challen Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Challen Biotechnology Co., Ltd.'s shares on secondary markets.